Exploring the Impact of Exposure to Primary Varicella in Children on Varicella-Zoster Virus Immunity of Parents
- 1 April 2011
- journal article
- research article
- Published by SAGE Publications in Viral Immunology
- Vol. 24 (2) , 151-157
Abstract
Varicella-zoster virus (VZV) causes both primary varicella, and through reactivation of the virus, herpes zoster. It is hypothesized that VZV-immune adults may reduce the probability of developing herpes zoster through exposure to varicella. In this study we examine the existence of immunological boosting in VZV-immune adults after close contact with primary varicella. We followed-up 18 parents with household exposure to primary varicella for 1 y. Fifteen age-matched healthy and 20 older volunteers served as control groups. Cellular (IFN-γ ELISPOT) and humoral responses were measured. Data analyses were performed by t-tests and linear mixed models. The young control group only showed higher cellular responses than the older control group and the exposed group 1 mo after exposure. The exposed group had a strong tendency toward higher cellular responses compared to the older control group, reaching significance 1 y post-exposure. The best fitting linear mixed model predicts a decline in cellular response of 50% between 1 wk and 1 mo post-exposure, followed by an increase to attain an 80% higher level at 1 y compared to the first week post-exposure. No significant results emerged based on the humoral response of the individual parents in the exposed group, despite a general tendency toward higher antibody concentrations in the exposed versus the control groups. No significant difference in humoral immunity was found between the control groups. One year after initial re-exposure to VZV, VZV-immune adults showed a rise in cellular response as assessed by IFN-γ ELISPOT, and steady-state levels for the humoral response.Keywords
This publication has 14 references indexed in Scilit:
- Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)Cancer Immunology, Immunotherapy, 2007
- Variability and gender differences in memory T cell immunity to varicella-zoster virus in healthy adultsVaccine, 2006
- Development of Virus‐Specific CD4+T Cells on Reexposure to Varicella‐Zoster VirusThe Journal of Infectious Diseases, 2004
- Decline in Varicella‐Zoster Virus (VZV)–Specific Cell‐Mediated Immunity with Increasing Age and Boosting with a High‐Dose VZV VaccineThe Journal of Infectious Diseases, 2003
- Contacts with varicella or with children and protection against herpes zoster in adults: a case-control studyThe Lancet, 2002
- Development and Validation of a Gamma Interferon ELISPOT Assay for Quantitation of Cellular Immune Responses to Varicella-Zoster VirusClinical and Diagnostic Laboratory Immunology, 2001
- Frequencies of Memory T Cells Specific for Varicella‐Zoster Virus, Herpes Simplex Virus, and Cytomegalovirus by Intracellular Detection of Cytokine ExpressionThe Journal of Infectious Diseases, 2000
- The Protective Effect of Immunologic Boosting against Zoster: An Analysis in Leukemic Children Who Were Vaccinated against ChickenpoxThe Journal of Infectious Diseases, 1996
- Varicella-Zoster Virus-Specific Immunity after Herpes ZosterThe Journal of Infectious Diseases, 1991
- Selective decline in cellular immune response to varicella‐zoster in the elderlyNeurology, 1980